Indo Us Bio-Tech Limited (NSE:INDOUS)
India · Delayed Price · Currency is INR 102.00
+3.79 (3.86%)
Apr 1, 2026, 3:29 PM IST
Indo Us Bio-Tech Revenue
Indo Us Bio-Tech had revenue of 227.98M INR in the quarter ending December 31, 2025, a decrease of -3.25%. This brings the company's revenue in the last twelve months to 1.18B, up 36.63% year-over-year. In the fiscal year ending March 31, 2025, Indo Us Bio-Tech had annual revenue of 1.04B with 42.56% growth.
Revenue (ttm)
1.18B
Revenue Growth
+36.63%
P/S Ratio
1.67
Revenue / Employee
n/a
Employees
883
Market Cap
1.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.04B | 310.02M | 42.56% |
| Mar 31, 2024 | 728.36M | 110.92M | 17.96% |
| Mar 31, 2023 | 617.45M | 116.86M | 23.34% |
| Mar 31, 2022 | 500.59M | 99.48M | 24.80% |
| Mar 31, 2021 | 401.10M | 3.49M | 0.88% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nagarjuna Fertilizers and Chemicals | 13.49B |
| Ramdevbaba Solvent | 9.13B |
| Indogulf Cropsciences | 6.87B |
| Nath Bio-Genes (India) | 4.46B |
| Nova Agritech | 2.87B |
| TBI Corn | 2.56B |
| ShreeOswal Seeds and Chemicals | 2.18B |
| Upsurge Seeds Of Agriculture | 1.33B |
Indo Us Bio-Tech News
- 1 year ago - Indo US Bio-Tech share price surges 3% after signing MoU for Pratap Hybrid Maize -6 - Business Upturn